Recent price increases affecting imported medications in Tunisia are under scrutiny. Kapitalis investigated the underlying causes of these hikes, suggesting the situation is more complex than initially understood. The report delves into the factors driving up costs, potentially impacting access to essential medicines for Tunisian citizens. Details regarding specific medications affected and the extent of the price increases were not provided in this brief announcement, but the full article promises further explanation. This investigation aims to uncover the "true reasons" beyond simple market fluctuations. The findings could have significant implications for healthcare policy and affordability in Tunisia. The complete article is available on Kapitalis.